Archives: Press Releases
Nissan Chemical and Modulus Discovery Jointly Announce Signing of Strategic Drug Discovery Collaboration Agreement
News -
21 April, 2021 -
Nissan Chemical Corporation (Head Office: Chuo-ku, Tokyo Japan; President: Shinsuke Yagi, “Nissan Chemical”), and Modulus Discovery, Inc. (Head Office: Chiyoda-ku, Tokyo Japan; CEO: S. Roy Kimura, Ph.D., “Modulus”), an early stage global biopharmaceutical company, jointly announced today the signing of a strategic drug discovery collaboration agreement. Under this agreement, the companies will collaboratively accelerate the ...continuedModulus Discovery, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
News -
14 December, 2020 -
Modulus Discovery Inc. (“Modulus”), a pre-clinical stage technology-driven drug discovery company announced today that it was invited to present at the 39th Annual J.P. Morgan Healthcare Conference in January 2021. The J.P. Morgan Healthcare Conference, which attracts over 500 companies and 12,000 investors, is going virtual for 2021, and the webcast will be made available ...continuedModulus Discovery Announces Signing of a Collaboration Agreement with the University Of Tokyo to Pursue Drug Discovery for COVID-19 and Related Emerging Virus Infections
News -
02 October, 2020 -
Modulus Discovery, Inc., a preclinical-stage technology-driven drug discovery company announced today the initiation of a research collaboration with Professor Tsutomu Suzuki of Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo to pursue drug discovery on a novel target for COVID-19 and related emerging virus infections. Emerging viruses are now becoming one ...continuedModulus Discovery Receives “Mizuho Innovation Award”
News -
28 July, 2020 -
We are pleased to announce that Modulus Discovery, Inc. has been awarded the Mizuho Innovation Award which recognizes the top innovative companies in Japan. We hope to work together with Mizuho Bank and capitalize on its broad industry ties to accelerate our search for much needed new medicines through our globally networked research model and ...continuedModulus Discovery Closes $25.5M USD Series B
News -
13 May, 2020 -
Tokyo, Japan – May 13, 2020 – Modulus Discovery, Inc., a preclinical-stage technology-driven drug discovery firm, announces the successful closing of its series B funding round in the amount of 2.71 B JPY (approximately $25.5M USD). Series B investors include SBI Investments Co., Ltd., Mizuho Capital Co., Ltd., JAFCO Co., Ltd., Keio Innovation Initiative, Inc., ...continuedModulus Discovery Announces Signing of Research Data Transfer Agreement with Astellas Pharma Inc.
News -
30 May, 2019 -
Modulus Discovery, Inc. (CEO: S. Roy Kimura, Ph.D., “Modulus”), an early stage global biopharmaceutical company, announced today the signing of research data transfer agreement on a specific drug target with Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”). Under the terms of the agreement, Modulus plans to design, evaluate and optimize ...continuedModulus Discovery Announces Signing of Collaboration Agreement with Tokyo Institute of Technology
News -
09 May, 2019 -
Modulus Discovery, Inc., an early stage global biopharmaceutical company, announced today the signing of a research collaboration agreement with Professor Masahito Oue, Assistant Professor of Tokyo Institute of Technology (“Tokyo Tech”). The collaboration will focus on the implementation and scale-up of Modulus’ cutting-edge TSUBAME 3.0 is recognized as one of the world’s most efficient supercomputers, ...continuedModulus Discovery Announces Senior Appointments including Jon Mason as Scientific Advisor
News -
28 January, 2019 -
Modulus Discovery, Inc., an early stage global biopharmaceutical company, announced today the appointment of Jonathan Mason, Ph.D. as Scientific Advisor to the Company, and William Sinko, Ph.D., as Principal Scientist, Computational Drug Discovery. Dr. Mason is a global leader and scientific expert in drug discovery, particularly in the development and application of computational technologies for ...continued